首頁 > 市場調查報告書 > 製藥

藥物開發臨床實驗臨床開發

市場調查報告書

商品編碼

1402453

2028 年歐洲臨床試驗市場預測 - 區域分析 - 按研究設計、階段和適應症

Europe Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design, Phase, and Indication

出版日期: 2023年10月26日 | 出版商:

The Insight Partners | 英文 148 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

歐洲臨床試驗市場預計將從2022年的157.3935億美元成長到2028年的216.4387億美元。預計2022年至2028年CAGR為5.5%。

臨床試驗的採用和外包的增加推動了歐洲臨床試驗市場。

臨床試驗有助於確定新的治療或預防形式（例如新藥、飲食或醫療設備）是否安全有效。試驗主要在藥物開發過程中進行。根據歐洲藥品管理局統計，歐盟（EU）每年授權約4,000項臨床試驗，其中約60%的臨床試驗與製藥業相關。由於慢性病盛行率的上升，越來越多的用於開發不同有效治療方法的臨床試驗正在推動臨床試驗市場的成長。

此外，臨床試驗的程序越來越複雜，因此對研究組織中發生的操作的正確執行和監督變得至關重要。為了避免因執行不當而出現錯誤，研究型組織正在外包臨床試驗來開發其產品。臨床研究組織 (CRO) 透過使用高品質設施和深厚的主題專業知識提供的服務，協助成功實施臨床試驗。 CRO 已開始透過其高效且具成本效益的營運使試驗申辦者受益，成為臨床試驗產業的支柱。因此，開發具有成本效益的解決方案以及減少藥物開發過程中 CRO 的錯誤正在推動臨床試驗市場的成長。

歐洲臨床試驗市場概況

歐洲臨床試驗市場已細分為英國、德國、法國、義大利、西班牙和歐洲其他地區。公司新藥開發和創新產品推出的臨床試驗活動數量不斷增加，可能會在預測期內促進歐洲市場的成長。

癌症、心血管疾病、神經系統疾病和傳染病是德國臨床試驗中最常研究的疾病。臨床研究受惠於德國完善的交通、通訊、能源和公共服務基礎設施，而且該國患者群體龐大，對優質醫療保健的需求很高。臨床試驗協調中心是聯邦教育和研究部新資助計畫的一部分，旨在促進學術臨床研究。德國的臨床試驗由聯邦藥品和醫療器材研究所或保羅-埃利希研究所批准，具體取決於要研究的產品。因此，德國的臨床試驗核准流程標準化、可靠、透明，且核准的研究啟動時間相對較短。此外，德國頂級 CRO 提供多種臨床試驗服務。 Sofpromed 管理德國和其他歐盟成員國的臨床試驗。它為製藥和生物技術公司提供全方位的CRO服務。同樣，總部位於德國曼海姆的 CONET GmbH 提供從小型試點研究到所有階段 (1-4) 的大型多中心國際臨床試驗的臨床試驗管理服務，包括根據歐盟指令的兒科臨床試驗和醫療器械試驗。

歐洲臨床試驗市場收入及2028年預測（百萬美元）

歐洲臨床試驗市場細分

歐洲臨床試驗市場分為階段、研究設計、適應症和國家。

根據階段，歐洲臨床試驗市場分為 I 期、II 期、III 期和 IV 期。 2022 年，III 期臨床試驗市佔率將成為歐洲最大的臨床試驗市場。

根據研究設計，歐洲臨床試驗市場分為介入性、觀察性和擴展性。 2022 年，介入性細分市場將佔據歐洲最大的臨床試驗市場。

根據適應症，歐洲臨床試驗市場分為自體免疫/發炎、疼痛管理、腫瘤、中樞神經系統疾病、糖尿病、肥胖、心血管等。到 2022 年，腫瘤學領域將佔據歐洲最大的臨床試驗市場。

根據國家/地區，歐洲臨床試驗市場分為英國、德國、法國、義大利、西班牙和歐洲其他地區。 2022年，德國在歐洲臨床試驗市場佔據主導地位。

Charles River Laboratories International Inc、ICON Plc、IQVIA Holdings Inc、IXICO Plc、Laboratory Corp of America Holdings、Parexel International Corp、SGS SA、Syneos Health Inc、Thermo Fisher Scientific Inc 和 WuXi AppTec Co Ltd. 都是領先公司在歐洲臨床試驗市場運作。

Clinical trials help determine if a new form of treatment or prevention, such as a new drug, diet, or medical device, is safe and effective. The trials are mainly carried out during drug development. According to European Medicine Agency, in the European Union (EU), ~4,000 clinical trials are authorized annually, of which about 60% of clinical trials are associated with the pharmaceutical industry. An increasing number of clinical trials for developing different effective treatments due to the rising prevalence of chronic diseases is fueling the growth of the clinical trials market.

Further, clinical trials are increasingly becoming complex procedures, owing to which proper execution and overseeing of the operation occurring in research-based organizations has become crucial. To avoid errors due to improper execution, research-based organizations are outsourcing clinical trials to develop their products. Clinical research organizations (CROs) assist in successfully implementing clinical trials through the services offered using high-quality facilities and deep subject matter expertise. CROs have begun acting as a backbone of the clinical trial industry through their efficient and cost-effective operations benefitting trial sponsors. Thus, the development of cost-effective solutions and decreasing errors in CROs during the drug development process are driving the clinical trials market growth.

Europe Clinical Trials Market Overview

The Europe clinical trials market has been segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The rising number of clinical trial activities for new drug development and innovative product launches by the companies will likely enhance the market growth in Europe during the forecast period.

Cancer, cardiovascular illness, nervous system disorders, and infectious diseases are the most frequently studied conditions in clinical trials in Germany. Clinical research benefits from Germany's well-established transport, communication, energy, and public services infrastructure, Moreover, there is a large patient pool and a high demand for quality healthcare in the country. Coordinating centers for clinical trials were established as part of a new funding program under the Federal Ministry of Education and Research to foster academic clinical research. Clinical trials in Germany are approved by the Federal Institute for Drugs and Medical Devices or the Paul-Ehrlich Institute, depending on the product to be investigated. Therefore, Germany's clinical trial approval processes are standardized, reliable, transparent, and approved for relatively short study start-up timelines. Further, top CROs in Germany provide several clinical trial services. Sofpromed manages clinical trials in Germany and other EU member states. It offers a full range of CRO services for pharmaceutical and biotechnology companies. Similarly, CONET GmbH, headquartered in Mannheim, Germany, offers clinical trial management services from small pilot studies to large multicenter international clinical trials for all phases (1-4), including pediatric clinical trials and medical device trials as per EU Directives.

Europe clinical trials market Revenue and Forecast to 2028 (US$ Million)

Europe Clinical Trials Market Segmentation

The Europe clinical trials market is segmented into phase, study design, indication, and country.

Based on phase, the Europe clinical trials market is segmented into phase I, phase II, phase III, and phase IV. The phase III segment registered the largest Europe clinical trials market share in 2022.

Based on study design, the Europe clinical trials market is segmented into interventional, observational, and expanded access. The interventional segment held the largest Europe clinical trials market share in 2022.

Based on indication, the Europe clinical trials market is segmented into autoimmune/inflammation, pain management, oncology, CNS condition, diabetes, obesity, cardiovascular, and others. The oncology segment held the largest Europe clinical trials market share in 2022.

Based on country, the Europe clinical trials market has been categorized into the UK, Germany, France, Italy, Spain, and Rest of Europe. Germany dominated the Europe clinical trials market in 2022.

Charles River Laboratories International Inc, ICON Plc, IQVIA Holdings Inc, IXICO Plc, Laboratory Corp of America Holdings, Parexel International Corp, SGS SA, Syneos Health Inc, Thermo Fisher Scientific Inc, and WuXi AppTec Co Ltd. are some of the leading companies operating in the Europe clinical trials market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe clinical trials market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe clinical trials market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the clinical trials market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Europe Clinical Trials Market - By Phase
- 1.3.2 Europe Clinical Trials Market - By Study Design
- 1.3.3 Europe Clinical Trials Market - By Indication
- 1.3.4 Europe Clinical Trials Market - By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Clinical Trials Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 Europe PEST Analysis
4.3 Experts Opinion

5. Europe Clinical Trials Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Adoption and Outsourcing of Clinical Trials
- 5.1.2 Flourishing Pharmaceutical Industry and Increasing R&D Activities in Pharmaceutical Industry
5.2 Market Restraints
- 5.2.1 Expensive and Time-Consuming Process
5.3 Market Opportunities
- 5.3.1 Adoption of Decentralized Clinical Trials and Hybrid Clinical Trials
5.4 Future Trends
- 5.4.1 AI-Driven Clinical Trials
5.5 Impact Analysis

6. Clinical Trials Market - Europe Analysis

6.1 Europe Clinical Trials Market Revenue Forecast and Analysis

7. Europe Clinical Trials Market Revenue and Forecast To 2028 - by Study Design

7.1 Overview
7.2 Europe Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)
7.3 Interventional
- 7.3.1 Overview
- 7.3.2 Interventional: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Observational
- 7.4.1 Overview
- 7.4.2 Observational: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Expanded Access
- 7.5.1 Overview
- 7.5.2 Expanded Access: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)

8. Europe Clinical Trials Market - By Phase

8.1 Overview
8.2 Europe Clinical Trials Market, by Phase, 2022 and 2028 (%)
8.3 Phase III
- 8.3.1 Overview
- 8.3.2 Phase III: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Phase II
- 8.4.1 Overview
- 8.4.2 Phase II: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Phase IV
- 8.5.1 Overview
- 8.5.2 Phase IV: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Phase I
- 8.6.1 Overview
- 8.6.2 Phase I: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)

9. Europe Clinical Trials Market Revenue and Forecast To 2028 - Indication

9.1 Overview
9.2 Europe Clinical Trials Market Revenue Share, by Indication (2022 and 2028)
9.3 Autoimmune/Inflammation
- 9.3.1 Overview
- 9.3.2 Autoimmune/Inflammation: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Pain Management
- 9.4.1 Overview
- 9.4.2 Pain Management: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Oncology
- 9.5.1 Overview
- 9.5.2 Oncology: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.6 CNS Condition
- 9.6.1 Overview
- 9.6.2 CNS Condition: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.7 Diabetes
- 9.7.1 Overview
- 9.7.2 Diabetes: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.8 Obesity
- 9.8.1 Overview
- 9.8.2 Obesity: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.9 Cardiovascular
- 9.9.1 Overview
- 9.9.2 Cardiovascular: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.10 Other
- 9.10.1 Overview
- 9.10.2 Other: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)

10. Europe Clinical Trials Market - Revenue and Forecast to 2028 - Country Analysis

10.1 Europe: Clinical Trials Market
- 10.1.1 Overview
- 10.1.2 Europe: Clinical Trials Market, by Country, 2022 & 2028 (%)
  - 10.1.2.1 Germany: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.1.1 Overview
    - 10.1.2.1.2 Germany: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.1.3 Germany: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
    - 10.1.2.1.4 Germany: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
    - 10.1.2.1.5 Germany: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
  - 10.1.2.2 UK: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.2.1 Overview
    - 10.1.2.2.2 UK: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.2.3 UK: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
    - 10.1.2.2.4 UK: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
    - 10.1.2.2.5 UK: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
  - 10.1.2.3 France: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.3.1 Overview
    - 10.1.2.3.2 France: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.3.3 France: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
    - 10.1.2.3.4 France: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
    - 10.1.2.3.5 France: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
  - 10.1.2.4 Italy: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.4.1 Overview
    - 10.1.2.4.2 Italy: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.4.3 Italy: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
    - 10.1.2.4.4 Italy: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
    - 10.1.2.4.5 Italy: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
  - 10.1.2.5 Spain: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.5.1 Overview
    - 10.1.2.5.2 Spain: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.5.3 Spain: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
    - 10.1.2.5.4 Spain: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
    - 10.1.2.5.5 Spain: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
  - 10.1.2.6 Rest of Europe: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.6.1 Overview
    - 10.1.2.6.2 Rest of Europe: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.6.3 Rest of Europe: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
    - 10.1.2.6.4 Rest of Europe: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
    - 10.1.2.6.5 Rest of Europe: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
- 11.3.1 Overview
11.4 Inorganic Developments
- 11.4.1 Overview

12. Company Profiles

12.1 IQVIA Holdings Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Parexel International Corp
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 IXICO Plc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Charles River Laboratories International Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 ICON Plc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 WuXi AppTec Co Ltd
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 SGS SA
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Syneos Health Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Thermo Fisher Scientific Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Laboratory Corp of America Holdings
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Germany: Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany: Clinical Trials Market, by Study Design - Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany: Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 4. UK Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 5. UK Clinical Trials Market, by Study Design - Revenue and Forecast to 2028 (US$ Million)
Table 6. UK Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 7. France: Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 8. France: Clinical Trials Market, by Study Design - Revenue and Forecast to 2028 (US$ Million)
Table 9. France: Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 10. Italy: Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 11. Italy: Clinical Trials Market, by Study Design - Revenue and Forecast to 2028 (US$ Million)
Table 12. Italy: Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 13. Spain: Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 14. Spain: Clinical Trials Market, by Study Design - Revenue and Forecast to 2028 (US$ Million)
Table 15. Spain: Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 16. Rest of Europe: Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of Europe: Clinical Trials Market, by Study Design - Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of Europe: Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 19. Organic Developments Done by Companies
Table 20. Inorganic Developments Done by Companies
Table 21. Glossary of Terms

List Of Figures

Figure 1. Europe Clinical Trials Market Segmentation
Figure 2. Europe Clinical Trials Market, By Region
Figure 3. Europe Clinical Trials Market Overview
Figure 4. Phase III Segment Held Largest Share of Phase Segment in Europe Clinical Trials Market
Figure 5. The UK is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Europe Experts Opinion
Figure 8. Impact Analysis
Figure 9. Europe Clinical Trials Market- Revenue Forecast and Analysis - 2020- 2028
Figure 10. Europe Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)
Figure 11. Interventional: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Observational: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Expanded Access: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Europe Clinical Trials Market, by Phase 2022 and 2028 (%)
Figure 15. Phase III: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Phase II: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Phase IV: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Phase I: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Europe Clinical Trials Market Revenue Share, by Indication (2022 and 2028)
Figure 20. Autoimmune/Inflammation: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Pain Management: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Oncology: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. CNS Condition: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Diabetes: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Obesity: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Cardiovascular: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Other: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Europe: Clinical Trials Market, by Key Country - Revenue (2022) (US$ Million)
Figure 29. Europe: Clinical Trials Market, by Country, 2022 & 2028 (%)
Figure 30. Germany: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. UK: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. France: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Italy: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. Spain: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 35. Rest of Europe: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 36. Growth Strategies Done by the Companies in the Market, (%)